RBFOX1 cooperates with MBNL1 to control splicing in muscle, including events altered in myotonic dystrophy type 1

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Klinck, Roscoe ^a   Fourrier, Angélique ^b   Thibault, Philippe ^a   Toutant, Johanne ^a   Durand, Mathieu ^a   Lapointe, Elvy ^a   Caillet Boudin, Marie Laure ^c   Sergeant, Nicolas ^c   Gourdon, Genevieve ^d   Meola, Giovanni ^e   Furling, Denis ^f   Puymirat, Jack ^b   Chabot, Benoit ^a  

^a UNIVERSITY OF SHERBROOKE   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c UNIV LILLE   (France)

^d IMAGINE INSTITUTE   (France)

^e UNIVERSITY OF MILAN   (Italy)

^f SORBONNE UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN MBNL1; PROTEIN RBFOX1; REGULATOR PROTEIN; RNA BINDING PROTEIN; UNCLASSIFIED DRUG; MBNL1 PROTEIN, HUMAN; RBFOX1 PROTEIN, HUMAN;

ACTN1 GENE; ARTICLE; CONTROLLED STUDY; CYTOSKELETON; DMD GENE; EMBRYO; GENE; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; KCND3 GENE; MYOTONIC DYSTROPHY; PROTEIN PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING; SORBS1 GENE; TACC2 GENE; TIN GENE; TRPM4 GENE; ADULT; ALTERNATIVE RNA SPLICING; ANIMAL; C57BL MOUSE; CELL LINE; FEMALE; GENETICS; MALE; METABOLISM; MIDDLE AGED; MYOBLAST; PHYSIOLOGY; SKELETAL MUSCLE; TRANSGENIC MOUSE;

ADULT; ALTERNATIVE SPLICING; ANIMALS; CELL LINE; FEMALE; HUMANS; MALE; MICE, INBRED C57BL; MICE, TRANSGENIC; MIDDLE AGED; MUSCLE, SKELETAL; MYOBLASTS; MYOTONIC DYSTROPHY; RNA-BINDING PROTEINS;

EID: 84922312619     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0107324     Document Type: Article

References (70)

1. Taneja KL, McCurrach M, Schalling M, Housman D, Singer RH (1995) Foci of trinucleotide repeat transcripts in nuclei of myotonic dystrophy cells and tissues. J Cell Biol 128: 995-1002.
2. Kalsotra A, Xiao X, Ward AJ, Castle JC, Johnson JM, et al. (2008) A postnatal switch of CELF and MBNL proteins reprograms alternative splicing in the developing heart. Proc Natl Acad Sci U S A 105: 20333-20338.
3. Timchenko NA, Cai ZJ, Welm AL, Reddy S, Ashizawa T, et al. (2001) RNA CUG repeats sequester CUGBP1 and alter protein levels and activity of CUGBP1. J Biol Chem 276: 7820-7826.
4. Paul S, Dansithong W, Kim D, Rossi J, Webster NJ, et al. (2006) Interaction of muscleblind, CUG-BP1 and hnRNP H proteins in DM1-associated aberrant IR splicing. EMBO J 25: 4271-4283.
5. Mankodi A, Lin X, Blaxall BC, Swanson MS, Thornton CA (2005) Nuclear RNA foci in the heart in myotonic dystrophy. Circ Res 97: 1152-1155.
6. Kuyumcu-Martinez NM, Wang GS, Cooper TA (2007) Increased steady-state levels of CUGBP1 in myotonic dystrophy 1 are due to PKC-mediated hyperphosphorylation. Mol Cell 28: 68-78.
7. Kuyumcu-Martinez NM, Cooper TA (2006) Misregulation of alternative splicing causes pathogenesis in myotonic dystrophy. Prog Mol Subcell Biol 44: 133-159.
8. Gomes-Pereira M, Cooper TA, Gourdon G (2011) Myotonic dystrophy mouse models: towards rational therapy development. Trends Mol Med 17: 506-517.
9. Mankodi A, Takahashi MP, Jiang H, Beck CL, Bowers WJ, et al. (2002) Expanded CUG repeats trigger aberrant splicing of ClC-1 chloride channel premRNA and hyperexcitability of skeletal muscle in myotonic dystrophy. Mol Cell 10: 35-44.
10. Charlet BN, Savkur RS, Singh G, Philips AV, Grice EA, et al. (2002) Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing. Mol Cell 10: 45-53.
11. Savkur RS, Philips AV, Cooper TA (2001) Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy. Nat Genet 29: 40-47.
12. Fugier C, Klein AF, Hammer C, Vassilopoulos S, Ivarsson Y, et al. (2011) Misregulated alternative splicing of BIN1 is associated with T tubule alterations and muscle weakness in myotonic dystrophy. Nat Med 17: 720-725.
13. Osborne RJ, Lin X, Welle S, Sobczak K, O'Rourke JR, et al. (2009) Transcriptional and post-transcriptional impact of toxic RNA in myotonic dystrophy. Hum Mol Genet 18: 1471-1481.
14. Du H, Cline MS, Osborne RJ, Tuttle DL, Clark TA, et al. (2010) Aberrant alternative splicing and extracellular matrix gene expression in mouse models of myotonic dystrophy. Nat Struct Mol Biol 17: 187-193.
15. Wang ET, Cody NA, Jog S, Biancolella M, Wang TT, et al. (2012) Transcriptome-wide regulation of pre-mRNA splicing and mRNA localization by muscleblind proteins. Cell 150: 710-724.
16. Huichalaf C, Sakai K, Jin B, Jones K, Wang GL, et al. (2010) Expansion of CUG RNA repeats causes stress and inhibition of translation in myotonic dystrophy 1 (DM1) cells. FASEB J 24: 3706-3719.
17. Timchenko NA, Wang GL, Timchenko LT (2005) RNA CUG-binding protein 1 increases translation of 20-kDa isoform of CCAAT/enhancer-binding protein beta by interacting with the alpha and beta subunits of eukaryotic initiation translation factor 2. J Biol Chem 280: 20549-20557.
18. Machuca-Tzili LE, Buxton S, Thorpe A, Timson CM, Wigmore P, et al. (2011) Zebrafish deficient for Muscleblind-like 2 exhibit features of myotonic dystrophy. Dis Model Mech 4: 381-392.
19. Hao M, Akrami K, Wei K, De Diego C, Che N, et al. (2008) Muscleblind-like 2 (Mbnl2) -deficient mice as a model for myotonic dystrophy. Dev Dyn 237: 403-410.
20. Kim DH, Langlois MA, Lee KB, Riggs AD, Puymirat J, et al. (2005) HnRNP H inhibits nuclear export of mRNA containing expanded CUG repeats and a distal branch point sequence. Nucleic Acids Res 33: 3866-3874.
21. Charizanis K, Lee KY, Batra R, Goodwin M, Zhang C, et al. (2012) Muscleblind-like 2-mediated alternative splicing in the developing brain and dysregulation in myotonic dystrophy. Neuron 75: 437-450.
22. Lin X, Miller JW, Mankodi A, Kanadia RN, Yuan Y, et al. (2006) Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy. Hum Mol Genet 15: 2087-2097.
23. Orengo JP, Chambon P, Metzger D, Mosier DR, Snipes GJ, et al. (2008) Expanded CTG repeats within the DMPK 39 UTR causes severe skeletal muscle wasting in an inducible mouse model for myotonic dystrophy. Proc Natl Acad Sci U S A 105: 2646-2651.
24. Mankodi A, Logigian E, Callahan L, McClain C, White R, et al. (2000) Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat. Science 289: 1769-1773.
25. Gomes-Pereira M, Foiry L, Nicole A, Huguet A, Junien C, et al. (2007) CTG trinucleotide repeat "big jumps": large expansions, small mice. PLoS Genet 3: e52.
26. Kanadia RN, Johnstone KA, Mankodi A, Lungu C, Thornton CA, et al. (2003) A muscleblind knockout model for myotonic dystrophy. Science 302: 1978-1980.
27. Ward AJ, Rimer M, Killian JM, Dowling JJ, Cooper TA (2010) CUGBP1 overexpression in mouse skeletal muscle reproduces features of myotonic dystrophy type 1. Hum Mol Genet 19: 3614-3622.
28. Koshelev M, Sarma S, Price RE, Wehrens XH, Cooper TA (2010) Heartspecific overexpression of CUGBP1 reproduces functional and molecular abnormalities of myotonic dystrophy type 1. Hum Mol Genet 19: 1066-1075.
29. Seznec H, Agbulut O, Sergeant N, Savouret C, Ghestem A, et al. (2001) Mice transgenic for the human myotonic dystrophy region with expanded CTG repeats display muscular and brain abnormalities. Hum Mol Genet 10: 2717-2726.
30. Huguet A, Medja F, Nicole A, Vignaud A, Guiraud-Dogan C, et al. (2012) Molecular, physiological, and motor performance defects in DMSXL mice carrying .1, 000 CTG repeats from the human DM1 locus. PLoS Genet 8: e1003043.
31. Furling D, Coiffier L, Mouly V, Barbet JP, St Guily JL, et al. (2001) Defective satellite cells in congenital myotonic dystrophy. Hum Mol Genet 10: 2079-2087.
32. Beaulieu D, Thebault P, Pelletier R, Chapdelaine P, Tarnopolsky M, et al. (2012) Abnormal prostaglandin E2 production blocks myogenic differentiation in myotonic dystrophy. Neurobiol Dis 45: 122-129.
33. Venables JP, Koh CS, Froehlich U, Lapointe E, Couture S, et al. (2008) Multiple and specific mRNA processing targets for the major human hnRNP proteins. Mol Cell Biol 28: 6033-6043.
34. Hellemans J, Mortier G, De Paepe A, Speleman F, Vandesompele J (2007) qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data. Genome Biol 8: R19.
35. Klinck R, Bramard A, Inkel L, Dufresne-Martin G, Gervais-Bird J, et al. (2008) Multiple alternative splicing markers for ovarian cancer. Cancer Res 68: 657-663.
36. Venables JP, Klinck R, Bramard A, Inkel L, Dufresne-Martin G, et al. (2008) Identification of alternative splicing markers for breast cancer. Cancer Res 68: 9525-9531.
37. Venables JP, Klinck R, Koh C, Gervais-Bird J, Bramard A, et al. (2009) Cancerassociated regulation of alternative splicing. Nat Struct Mol Biol 16: 670-676.
38. Storey JD, Tibshirani R (2003) Statistical significance for genomewide studies. Proc Natl Acad Sci U S A 100: 9440-9445.
39. Assmann EM, Alborghetti MR, Camargo ME, Kobarg J (2006) FEZ1 dimerization and interaction with transcription regulatory proteins involves its coiled-coil region. J Biol Chem 281: 9869-9881.
40. Halpain S, Dehmelt L (2006) The MAP1 family of microtubule-associated proteins. Genome Biol 7: 224.
41. Velazquez-Bernardino P, Garcia-Sierra F, Hernandez-Hernandez O, Bermudez de Leon M, Gourdon G, et al. (2011) Myotonic dystrophy type 1-associated CTG repeats disturb the expression and subcellular distribution of microtubuleassociated proteins MAP1A, MAP2, and MAP6/STOP in PC12 cells. Mol Biol Rep 39: 415-424.
42. Yamashita Y, Matsuura T, Shinmi J, Amakusa Y, Masuda A, et al. (2012) Four parameters increase the sensitivity and specificity of the exon array analysis and disclose 25 novel aberrantly spliced exons in myotonic dystrophy. J Hum Genet 57: 368-374.
43. Eden E, Navon R, Steinfeld I, Lipson D, Yakhini Z (2009) GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists. BMC Bioinformatics 10: 48.
44. Molinari S, Relaix F, Lemonnier M, Kirschbaum B, Schafer B, et al. (2004) A novel complex regulates cardiac actin gene expression through interaction of Emb, a class VI POU domain protein, MEF2D, and the histone transacetylase p300. Mol Cell Biol 24: 2944-2957.
45. Rensen S, Merkx G, Doevendans P, Geurts Van Kessel A, van Eys G (2000) Structure and chromosome location of Smtn, the mouse smoothelin gene. Cytogenet Cell Genet 89: 225-229.
46. Tiwari S, Zhang Y, Heller J, Abernethy DR, Soldatov NM (2006) Atherosclerosis-related molecular alteration of the human CaV1.2 calcium channel alpha1C subunit. Proc Natl Acad Sci U S A 103: 17024-17029.
47. Kolmerer B, Olivieri N, Witt CC, Herrmann BG, Labeit S (1996) Genomic organization of M line titin and its tissue-specific expression in two distinct isoforms. J Mol Biol 256: 556-563.
48. Burkin DJ, Gu M, Hodges BL, Campanelli JT, Kaufman SJ (1998) A functional role for specific spliced variants of the alpha7beta1 integrin in acetylcholine receptor clustering. J Cell Biol 143: 1067-1075.
49. Orengo JP, Ward AJ, Cooper TA (2011) Alternative splicing dysregulation secondary to skeletal muscle regeneration. Ann Neurol 69: 681-690.
50. Nakahata S, Kawamoto S (2005) Tissue-dependent isoforms of mammalian Fox- 1 homologs are associated with tissue-specific splicing activities. Nucleic Acids Res 33: 2078-2089.
51. Auweter SD, Fasan R, Reymond L, Underwood JG, Black DL, et al. (2006) Molecular basis of RNA recognition by the human alternative splicing factor Fox-1. EMBO J 25: 163-173.
52. Underwood JG, Boutz PL, Dougherty JD, Stoilov P, Black DL (2005) Homologues of the Caenorhabditis elegans Fox-1 protein are neuronal splicing regulators in mammals. Mol Cell Biol 25: 10005-10016.
53. Jin Y, Suzuki H, Maegawa S, Endo H, Sugano S, et al. (2003) A vertebrate RNA-binding protein Fox-1 regulates tissue-specific splicing via the pentanucleotide GCAUG. EMBO J 22: 905-912.
54. Damianov A, Black DL (2010) Autoregulation of Fox protein expression to produce dominant negative splicing factors. RNA 16: 405-416.
55. Kiehl TR, Shibata H, Vo T, Huynh DP, Pulst SM (2001) Identification and expression of a mouse ortholog of A2BP1. Mamm Genome 12: 595-601.
56. Gallagher TL, Arribere JA, Geurts PA, Exner CR, McDonald KL, et al. (2011) Rbfox-regulated alternative splicing is critical for zebrafish cardiac and skeletal muscle functions. Dev Biol 359: 251-261.
57. Gehman LT, Stoilov P, Maguire J, Damianov A, Lin CH, et al. (2011) The splicing regulator Rbfox1 (A2BP1) controls neuronal excitation in the mammalian brain. Nat Genet 43: 706-711.
58. Howell VM, de Haan G, Bergren S, Jones JM, Culiat CT, et al. (2008) A targeted deleterious allele of the splicing factor SCNM1 in the mouse. Genetics 180: 1419-1427.
59. Howell VM, Jones JM, Bergren SK, Li L, Billi AC, et al. (2007) Evidence for a direct role of the disease modifier SCNM1 in splicing. Hum Mol Genet 16: 2506-2516.
60. Zhang Q, Bethmann C, Worth NF, Davies JD, Wasner C, et al. (2007) Nesprin- 1 and -2 are involved in the pathogenesis of Emery Dreifuss muscular dystrophy and are critical for nuclear envelope integrity. Hum Mol Genet 16: 2816-2833.
61. Li Z, Takakura N, Oike Y, Imanaka T, Araki K, et al. (2003) Defective smooth muscle development in qkI-deficient mice. Dev Growth Differ 45: 449-462.
62. Zhao L, Ku L, Chen Y, Xia M, LoPresti P, et al. (2006) QKI binds MAP1B mRNA and enhances MAP1B expression during oligodendrocyte development. Mol Biol Cell 17: 4179-4186.
63. Hall MP, Nagel RJ, Fagg WS, Shiue L, Cline MS, et al. (2013) Quaking and PTB control overlapping splicing regulatory networks during muscle cell differentiation. RNA 19: 627-638.
64. Pistoni M, Shiue L, Cline MS, Bortolanza S, Neguembor MV, et al. (2013) Rbfox1 downregulation and altered calpain 3 splicing by FRG1 in a mouse model of Facioscapulohumeral muscular dystrophy (FSHD). PLoS Genet 9: e1003186.
65. Venables JP, Brosseau JP, Gadea G, Klinck R, Prinos P, et al. (2013) RBFOX2 is an important regulator of mesenchymal tissue-specific splicing in both normal and cancer tissues. Mol Cell Biol 33: 396-405.
66. Bland CS, Wang ET, Vu A, David MP, Castle JC, et al. (2010) Global regulation of alternative splicing during myogenic differentiation. Nucleic Acids Res 38: 7651-7664.
67. Venables JP, Lapasset L, Gadea G, Fort P, Klinck R, et al. (2013) MBNL1 and RBFOX2 cooperate to establish a splicing programme involved in pluripotent stem cell differentiation. Nat Commun 4: 2480.
68. Sergeant N, Sablonniere B, Schraen-Maschke S, Ghestem A, Maurage CA, et al. (2001) Dysregulation of human brain microtubule-associated tau mRNA maturation in myotonic dystrophy type 1. Hum Mol Genet 10: 2143-2155.
69. Dhaenens CM, Schraen-Maschke S, Tran H, Vingtdeux V, Ghanem D, et al. (2008) Overexpression of MBNL1 fetal isoforms and modified splicing of Tau in the DM1 brain: two individual consequences of CUG trinucleotide repeats. Exp Neurol 210: 467-478.
70. Carpentier C, Ghanem D, Fernandez-Gomez FJ, Jumeau F, Philippe JV, et al. (2014) Tau exon 2 responsive elements deregulated in myotonic dystrophy type I are proximal to exon 2 and synergistically regulated by MBNL1 and MBNL2. Biochim Biophys Acta 1842: 654-664.